UBS Group AG Has $34.03 Million Holdings in Plexus Corp. $PLXS

UBS Group AG cut its position in shares of Plexus Corp. (NASDAQ:PLXS) by 10.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 231,508 shares of the technology company’s stock after selling 28,199 shares during the quarter. UBS Group AG’s holdings in Plexus were worth $34,032,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Plexus by 0.6% during the third quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock worth $533,016,000 after buying an additional 22,374 shares during the period. American Century Companies Inc. increased its position in shares of Plexus by 44.2% during the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after buying an additional 338,119 shares during the period. State Street Corp increased its position in shares of Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock worth $143,361,000 after buying an additional 24,115 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its position in shares of Plexus by 4.0% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company’s stock worth $132,434,000 after buying an additional 35,237 shares during the period. Finally, Northern Trust Corp increased its position in shares of Plexus by 1.5% during the third quarter. Northern Trust Corp now owns 340,964 shares of the technology company’s stock worth $49,334,000 after buying an additional 4,929 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Plexus

In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the firm’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total value of $1,921,557.40. Following the transaction, the chief operating officer directly owned 12,809 shares of the company’s stock, valued at approximately $2,579,732.60. This trade represents a 42.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Patrick John Jermain sold 2,321 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $201.12, for a total transaction of $466,799.52. Following the completion of the transaction, the chief financial officer directly owned 14,561 shares in the company, valued at $2,928,508.32. This trade represents a 13.75% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,621 shares of company stock valued at $6,578,664 over the last ninety days. 1.78% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Needham & Company LLC raised their price target on shares of Plexus from $206.00 to $285.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Stifel Nicolaus set a $250.00 price target on shares of Plexus and gave the stock a “buy” rating in a report on Monday, April 20th. Weiss Ratings cut shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, April 24th. Williams Trading set a $195.00 price target on shares of Plexus in a report on Wednesday, January 28th. Finally, Raymond James Financial restated an “outperform” rating and issued a $275.00 price target on shares of Plexus in a report on Thursday, April 30th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Plexus currently has an average rating of “Moderate Buy” and a consensus target price of $229.17.

Plexus Trading Up 2.2%

NASDAQ:PLXS opened at $266.55 on Friday. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $7.14 billion, a price-to-earnings ratio of 38.97 and a beta of 0.88. The firm has a fifty day simple moving average of $215.60 and a two-hundred day simple moving average of $181.45. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $275.83.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.13 billion. During the same period last year, the company posted $1.66 earnings per share. The business’s quarterly revenue was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Analysts expect that Plexus Corp. will post 6.23 EPS for the current fiscal year.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.